| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 899,362 | 19,705,000 | 9.73% | ||
| 2 | NEOGENOMICS INC | 2,971,545 | 17,027,000 | 8.41% | ||
| 3 | RTI SURGICAL HOLDINGS INC COM | 1,996,191 | 11,338,000 | 5.60% | ||
| 4 | AKORN INC | 324,480 | 9,249,000 | 4.57% | ||
| 5 | TEARLAB CORP | 3,764,165 | 7,566,000 | 3.74% | ||
| 6 | HARVARD BIOSCIENCE INC | 1,982,194 | 7,493,000 | 3.70% | ||
| 7 | ENZO BIOCHEM INC | 2,226,001 | 7,056,000 | 3.49% | ||
| 8 | Oxford Immunotec Global PLC | 520,755 | 7,030,000 | 3.47% | ||
| 9 | LHC GROUP INC COM | 152,441 | 6,825,000 | 3.37% | ||
| 10 | IGI LABS INC | 1,011,217 | 6,613,000 | 3.27% | ||
| 11 | OMNICELL COM COM | 172,429 | 5,363,000 | 2.65% | ||
| 12 | INSMED INC COM PAR .01 | 272,393 | 5,058,000 | 2.50% | ||
| 13 | BIO TECHNE CORP | 54,286 | 5,019,000 | 2.48% | ||
| 14 | LIGAND PHARMACEUTICALS INC | 57,571 | 4,931,000 | 2.44% | ||
| 15 | CYNAPSUS THERAPEUTICS INC | 302,194 | 4,886,000 | 2.41% | ||
| 16 | PHYSICIANS RLTY TR | 321,979 | 4,859,000 | 2.40% | ||
| 17 | LEMAITRE VASCULAR INC COM | 376,211 | 4,586,000 | 2.27% | ||
| 18 | ARRAY BIOPHARMA INC COM | 988,589 | 4,508,000 | 2.23% | ||
| 19 | ENTELLUS MEDICAL INC | 242,532 | 4,370,000 | 2.16% | ||
| 20 | QUIDEL CORP COM | 201,067 | 3,796,000 | 1.88% | ||
| 21 | NXSTAGE MED INC COM | 240,229 | 3,788,000 | 1.87% | ||
| 22 | ALKERMES PLC SHS | 64,148 | 3,764,000 | 1.86% | ||
| 23 | ANGIODYNAMICS INC | 277,323 | 3,658,000 | 1.81% | ||
| 24 | SPECTRANETICS CORP | 285,596 | 3,367,000 | 1.66% | ||
| 25 | MEDICINES CO | 84,103 | 3,193,000 | 1.58% | ||
| 26 | CEPHEID | 64,271 | 2,905,000 | 1.44% | ||
| 27 | STREAMLINE HEALTH SOLUTIONS COM | 1,255,148 | 2,874,000 | 1.42% | ||
| 28 | Arrowhead Pharma Inc | 465,503 | 2,681,000 | 1.32% | ||
| 29 | VERACYTE INC | 564,932 | 2,650,000 | 1.31% | ||
| 30 | HEALTHSTREAM INC COM | 118,352 | 2,581,000 | 1.27% | ||
| 31 | VERTEX PHARMACEUT | 24,643 | 2,566,000 | 1.27% | ||
| 32 | CELLDEX THERAPEUTICS INC NEW | 215,137 | 2,268,000 | 1.12% | ||
| 33 | ENDOLOGIX INC | 180,963 | 2,219,000 | 1.10% | ||
| 34 | BIOMARIN | 19,153 | 2,017,000 | 1.00% | ||
| 35 | KARYOPHARM THERAPEUTICS INC COM | 154,710 | 1,629,000 | 0.80% | ||
| 36 | BLUEBIRD BIO INCORPORATED | 13,623 | 1,165,000 | 0.58% | ||
| 37 | Esperion Therapeutics Inc | 47,965 | 1,131,000 | 0.56% | ||
| 38 | ARATANA THERAPEUTICS INC COM | 82,911 | 701,000 | 0.35% | ||
| 39 | HUMANA | 3,540 | 634,000 | 0.31% | ||
| 40 | ANTHEM INC | 4,095 | 573,000 | 0.28% | ||
| 41 | AETNA INC NEW | 5,215 | 571,000 | 0.28% | ||
| 42 | ENDO INTL | 8,161 | 565,000 | 0.28% | ||
| 43 | NOVARTIS A G | 6,070 | 558,000 | 0.28% | ||
| 44 | ALLERGAN PLC | 2,035 | 553,000 | 0.27% | ||
| 45 | UNITED THERAPEUTICS | 3,820 | 501,000 | 0.25% | ||
| 46 | BRISTOL MYERS SQUIBB CO | 8,290 | 491,000 | 0.24% | ||
| 47 | CELGENE CORP | 4,280 | 463,000 | 0.23% | ||
| 48 | LILLY ELI & CO | 5,495 | 460,000 | 0.23% | ||
| 49 | BECTON DICKINSON & CO | 3,395 | 450,000 | 0.22% | ||
| 50 | STERIS PLC | 6,330 | 411,000 | 0.20% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-15-003446, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
